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structure-activity relaionshps oftwele different PAHIs. The PAHs used were naphtlene, 1-
methylnaphthalene, 2-m2-methylanthracene, 9-
methylanthracene, 9,10dimehyla ene, p an , fluorene, 1-methyfiuorene, and fluo-
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the aqueous solublity ofthe PAHs. The preSent study revealed that there are strucumr detemi-
nants ofep ti toDity as t ned by GJIC actity. Key word rnes fluoranthene,
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Polycyclic aromatic hydrocarbons (PAHs)
are common environmental pollutants
formed during incomplete combustion; they
are also found in petroleum products and in
wood-processing chemical mixtures. The
PAHs are ofconcern because theyhave been
shown to induce tumors in experimental
animals (1). Occupational exposures of
humans to PAH-containing products have
been linked to cancer as early as 1775, when
increased scrotal cancer in chimney sweeps
was attributed to exposure to soot (2).
Exposure to high levels ofPAHs appears to
result in an increased risk ofmortality from
lung, prostate, and kidney cancers as docu-
mented in exposure studies in coke oven
workers and residents exposed to unvented
coal or wood smoke (3-5). Considerable
research has been devoted to predicting the
carcinogenicity ofPAHs based on the corre-
lation ofchemical structure and genotoxicity
(6-8). Although the first stage of cancer
(tumor initiation) often requires genotox-
ic/mutagenic events (9,10), the second stage
of cancer (tumor promotion) is a conse-
quence of a series of reversible epigenetic
events (10-13). Therefore, epigenetic data
should also play avital role in predicting the
carcinogenicity of PAHs based on chemical
structure; however, such data of epigenicity
is lacking in the literature.
Extracellular, intracellular, and intercel-
lular communication play a crucial role in
the epigenetic changes of gene expression
(14-18). In particular, intercellular commu-
nication through gap junctions provides the
crucial link of a cell with its neighboring
cells, thus enabling individual cells to exist
communally as a multicellular organism
(15-20). Because most cancer cells do not
behave in harmony with their neighbors, it
is not surprising that the down regulation of
gap junctional intercellular communication
(GJIC) results in uncontrolled cellular
growth leading to the development of
tumors (15,20). Evidence supports the
hypothesis that inhibited GJIC activity is
related to carcinogenesis (19-249: most, if
not all cancer cells, have dysfunctional
GJIC; endogenous and exogenous tumor-
promoting agents reversibly inhibit GJIC;
oncogenes down regulate GJIC; tumor
suppressor genes and antitumor promoters
up regulate GJIC; and transfection of gap
junction genes into GJIC-deficient and
tumorigenic cells restores GJIC and normal
growth regulation.
Understanding ofthe molecular basis of
the carcinogenicity of PAHs will therefore
need to include a study ofepigenetic events
such as those that affect GJIC. For exam-
ple, newborn mice treated with three
intraperitoneal doses of fluoranthene
showed an increase of lung and liver
tumors (23,24), but in other studies, there
was no evidence oftumor-initiating activity
in experimental animals (1) or in vivo geno-
toxicity, as assessed using the mouse bone
marrow micronudeus and rat liver unsched-
uled DNA synthesis assays (25). Although
the tumor-promoting activity of fluoran-
thene has not been determined, fluoran-
thene was shown to inhibit GJIC in a rat
liver epithelial cell line (26), which indicates
that fluoranthene may be a tumor promoter
because ofits epigenetic properties.
Upham et al. (27) showed a structural
relationship between various monomethyl
isomers of anthracene and GJIC activity.
The inhibitory monomethyl isomers of
anthracene possess a baylike region, whereas
anthracene and the monomethyl isomerwith
no baylike region do not inhibit GJIC. The
purpose of this study was to determine if
PAHs with a baylike region (formed from
methyl substitution) and PAHs containingan
actual bay region (formed by fused rings) are
more potent inhibitors of GJIC than the
more linear PAH analogues and how these
compounds compare with the anthracenes.
The description ofbay versus baylike regions
is shown in Figure 1. The aromatic hydro-
carbons used in this study are naphthalene,
1-methylnaphthalene, 2-methylnaphthalene,
anthracene, 1-methylanthracene, 2-methyl-
anthracene, 9-methylanthracene, 9,10-
dimethylanthracene, phenanthrene, fluo-
rene, 1-methylfluorene, and fluoranthene.
The basic structures of these chemicals are
shown in Figure 1.
These PAHs are some of the most
prominent compounds of the very tumori-
genic portion ofcigarette smoke condensates
(28R. In particular, the most abundant PAHs
in this neutral fraction were shown to be
methylated anthracenes and phenanthrenes
(1,494 ng/cigarette), and most of the
remaining PAHs are benzo(a)pyrene,
methylchrysene, chrysene, fluoranthene,
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pyrene, methylpyrene, anthracene, and
phenanthrene, ranging in concentrations of
24-360 nglcigarette (28).
Materials and Methods
Chemicab. Anthracene, 1-methylanthracene,
2-methylanthracene, 9-methylanthracene,
9,10-dimethylanthracene, naphthalene, 1-
methylnaphthalene, 2-methylnaphthalene,
fluorene, fluoranthene, 1-methylfluorene,
andformaldehyde (37%) were obtained from
Aldrich Chemical Co., Inc. (Milwaukee,
WI). Phenanthrene, neutral red, and lucifer
yellow were obtained from Sigma Chemical
Co. (St. Louis, MO). Acetonitrile was
obtainedfromEM Science (Gibbstown, NJ).
Stocksolutions. PAHs were dissolved in
100% acetonitrile. Concentrations ofstock
solutions ranged from 5 to 30 mM,
depending upon the solubility ofthe com-
pound in acetonitrile. The volumes of the
stock solutions that were added directly to
the culture medium in each plate ranged
from 2 to 35 pl. Vehicle controls were
added to the cells at a volume of acetoni-
trile equivalent to the volume of PAH
stock solution used. Acetonitrile was used
because it is noncytotoxic and noninhibito-
ry up to 2% (v/v) (26). Cells were exposed
to a maximum of 1.8% (v/v) acetonitrile in
culture medium. Due to the low aqueous
solubility of the chemicals, the maximum
concentration ofmost ofthe PAHs achiev-
able in the culture medium was 350 PM.
Cellcultures. WB-F344 rat liver epithe-
lial cell lines were obtained from J.W.
Grisham and M.S. Tsao of the University
ofNorth Carolina (Chapel Hill, NC) (29).
This cell line was used because much ofthe
in vivo tumor promotion assays were done
in rat liver, specifically in the Fischer 344
rats. The WB-344 cell line was designed to
match in vitrowork in a liver cell line from
the same strain of rat. Also the WB-344
cell line is an immortalized diploid cell line
that is nontumorigenic (29), has been well
characterized around the world for its
expressed gap junction genes and its ability
to perform GJIC via all available tech-
niques (19), has been tested with all kinds
of tumor-promoting chemicals for their
ability to block GJIC (19), and has been
tested for the ability ofgrowth factors and
oncogenes to modulate GJIC (19).
Cells were cultured in 2 ml D-medium
(formula no. 78-5470EG; Gibco Labora-
tories, Grand Island, NY) and supplement-
ed with 5% fetal bovine serum (Gibco) and
50 pg/ml gentamicin (Gibco). The cells
were grown in 35-mm diameterplastic petri
dishes (Corning Glass Works, Corning,
NY) and incubated at 370C in ahumidified
atmosphere containing 5% CO2 and 95%
air. Bioassays were conducted on confluent
cells that were obtained after 2-3 days of
growth.
Chemical treatments. In the dose-
response experiments, cells were exposed to
different doses ofthe target compound for a
set period oftime, and threshold values for
inhibitory doses were determined. In the
time-response experiments, cells were
exposed for various lengths of time to the
target compound at a dose that was known
to cause inhibition ofGJIC.
In the time recovery experiments, cells
were exposed to the target compound at a
dose and for a length of time that caused
inhibition of GJIC. Following chemical
exposure, the PAH-containing medium
was discarded and cells were washed five
times with phosphate-buffered saline (PBS)
and recultured in fresh PAH-free medium
forvarious incubation times.
Gapjunctional intercellular communi-
cation. GJIC was determined by using the
scrape loading/dye transfer (SL/DT) assay
adapted from El-Foulyetal. (30). Following
the chemical exposures, cells were rinsed five
times with PBS, and then approximately 1
ml 0.05% lucifer yellow dye (dissolved in
PBS) was added to the cells. A surgical steel
blade was used to make 8-10 scrapes
through the monolayer of cells. After a 3-
min incubation time at room temperature,
the dye was discarded and the cells were
rinsed five times with PBS and then fixed
with approximately 0.5 ml 4% formalin.
The SL/DT assaywas done immediately fol-
lowing chemical exposure or, with respect to
the time recovery experiments, following the
reincubation period.
The migration ofthe dye in the cells was
observed using a Nikon epifluorescence
phase microscope, illuminated with an
Osram HBO 200 W lamp and equipped
with a 35mm camera (Nikon Inc., Nikon,
Japan). Photographs ofthe cells were taken
at a magnification of 200x. Ten equally
spaced measurements (1 cm apart) were
madeon each200xphotograph, andthe dis-
tance the dye traveled was measured perpen-
dicular to the cut. The average distance of
dye migration was determined by averaging
these 10 measurements and was normally
200 pm. GJIC was assessed by comparing
the distance the dye traveled in the chemical-
ly treated cells to the distance the dye trav-
eled in thevehide controls. GJICwas report-
ed as a fraction of the control (FOC). An
FOC value ofapproximately 1.0 indicates
normal GJIC, and FOC values less than 1.0
indicate inhibition. All experiments were
done at least in triplicate, and the results
were reported as mean ± standard deviation
(SD) atthe95% confidence interval.
Cytotoxicity. Cytotoxicity was deter-
mined by the neutral red dye uptake assay
Figure 1. The basic structures of polycyclic aro-
matic hydrocarbons used inthis study.
developed by Borenfreund and Puerner
(31). Asolution ofneutral red dye (0.033%)
in D-medium was incubated at 370C for
approximately2 hr. The neutral redsolution
was centrifuged at 1,300 rpm and filtered
through a 0.22-pm Millipore syringe filter
(Millipore Corp., New Bedford, MA). After
chemical treatment, the cellswere rinsed five
times with PBS; the growth medium con-
taining the neutral red dye was then added.
The cells were incubated at 37°C in a
humidified atmosphere containing 95% air
and 5% CO2 for 1.5 hr. After incubation,
the cells were rinsed three times with PBS,
and 2 ml ofneutral red solubilizer (an aque-
ous solution containing 1% acetic acid and
50% ethanol) was added to lyse the cells.
Thesolubiized dyewas measured at awave-
length of 540 nm using a Beckman DU
7400 diode array detector (Beckman
Instruments, Inc., Schaumburg, IL).
Background absorbance at 690 nm was sub-
tracted from the absorbance ofthe analyte,
measured at 540 nm. Cytotoxicity was
reported as FOC. The average rate ofdye
uptake by the control cells was 1.088 ±
0.193 OD540=/hr (mean ± SD). An FOC
value ofapproximately 1.0 indicates that the
neutral red uptake was equivalent to that of
the vehicle control. An FOC value of less
than 1.0 indicates less neutral red uptake as
compared to the controls, and a cytotoxic
response to the target compound at the con-
centrations tested.
Data analysis. All data were compared
to and expressed as an FOC. Each value
represents the mean FOC of at least three
measurements from three different culture
plates ± the SD at the 95% confidence
interval. Curve fitting was done using
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Figure 4. The effect offluorene-type polycyclic aro-
matic hydrocarbons on gap junctional intercellular
communication (GJIC). The incubation time was 10
min and the rate ofdye migration in the control was
79.6 ± 7.0 pm/min (mean ± standard deviation).
SigmaPlot (Jandel Scientific Software,
Jandel Corp., San Rafael, CA), which uses
the Marquardt-Levenberg algorithm of a
least squares fit.
Results
Dose response. Naphthalene and 2-methyl-
naphthalene partially inhibited GJIC at a
dose of 350 pM (Fig. 2). 1-Methyl-
naphthalene completely inhibited GJIC at a
concentration of 225 pM (Fig. 2).
Anthracene and 2-methylanthracene did not
300 inhibit GJIC up to a dose of 350 pM (Fig.
3). Phenanthrene, 1-methylanthracene, 9-
methylanthracene, and 9,10-dimethylan-
petypnetponly thracene inhibited GJIC at 70 pM (Fig. 3).
The incuba- Fluoranthene and 1-methylfluorene were
lye migration more inhibitory of GJIC than was fluorene
mean ± stan- (Fig. 4). Fluoranthrene and fluorene inhibit-
ed GJIC at 65 pM, whereas fluorene inhibit-
edGJIC at 100 pM.
lanthracene Cytotoxicity. The 3-ring PAHs and fluo-
lnthracene rene-type PAHs were notcytotoxic (Fig. 5) at
* doses that inhibited GJIC, whereas the
methylnaphthalenes were cytotoxic at doses
that wereonlyslightlyhigher in concentration
than the dose which was inhibitory to GJIC
(Fig. 6). Increased incubation time of 1-
methylnaphthalene at a sublethal dose result-
ed in an increasedcytotoxicresponse (Fig. 7).
Time recovery. When the cells were
allowed to recover in fresh medium in the
absence ofthe target compound, GJIC was
restored significantly within the first hour.
GJIC was completely restored within 4 hr
(Fig. 8). Recovery was similar for all ofthe
200 400 compounds tested.
Time response. Both 1-methylnaphtha-
lene and 2-methylnaphthalene inhibited
(clic aromatic GJIC within the first 30 sec ofexposure to
rcellular com- the target compound (Fig. 9). Inhibition of
newas 10 min GJIC in cells treated with the 3-ring and
a control was fluorene-type PAHs occurred within 5 min
eviation). (Fig. 9). A linear relationship was observed
between the log octanol/water partition
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coefficient (log K0 ) and the time required
for each PAH to inhibit GJIC at a value of
0.5 ofthe FOC. The time ofinhibition at
0.5 FOC was calculated using the statisti-
cally determined values ofa four parameter
logistic function to describe a sigmoidal
curve (Eq. 1), which was determined for
each of the PAHs (Table 1), and solving
for xwhenfx) = 0.5.
f(X)[= e( )]+d
fix) is the fraction of the control, x is the
incubation time of the chemical with the
cells in minutes, ais the range ofFOC, bis
the slope coefficient, c is the inflection
point of the curve, and d is the minimum
FOC. Similarly, a linear regression of the
relationship of log Kw versus the dose at
0.5 FOC was determined for all 12 of the
PAHs, generating the following equation:
logK0w = -0.0015(pM) + 4.81 (2)
with an r2 <0.081. Clearly there was not a
linear relationship between log K., and
dose. Because anthracene and 2-methylan-
thracene did not inhibit GJIC, we used the
highest dose tested; this is why we reported
the r2 value as less than 0.081.
Discussion
We have specifically compared a structur-
al-functional relationship between the bay
or baylike regions ofPAHs and GJIC. The
term bay region refers to the pocket formed
by the sterically hindered region created by
an angular benzo ring (Fig. 1). Similarly,
the term baylike region is used to describe
the angular pocket formed at the top ofthe
benzene ring by a methyl group (Fig. 1).
However, we should note that the bay and
baylike regions discussed are not those
formed by the well-known DNA reactive
diolepoxides, but rather the unmetabolized
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Figure 5. Cytotoxicity of anthracene-, phenan-
threne-, and fluorene-type polycyclic aromatic
hydrocarbons.
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Figure 6. Cytotoxicity of naphthalene-type poly-
cyclic aromatic hydrocarbons.
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parent structure. Our focus was on the epi-
genetic effects of PAHs, which does not
require the metabolic activation of a PAH
to a chemically more reactive electrophilic
compound.
The napthalene-type PAHs inhibited
GJIC in a shorter time period (Fig. 2) and
were cytotoxic at higher doses and incuba-
tion times (Fig. 6, Fig. 7), whencompared to
the other PAHs (Fig. 5). The effect of
napthalene-type PAHs on GJIC could par-
tially be due to agreater cytotoxicity, but the
magnitude ofinhibition was greater with 1-
methylnaphthalene, which contained a bay-
like region. Naphthalene was shown to
induce oxidative stress in rats (32); therefore,
the cytotoxicity ofthe naphthalenes could be
a consequence ofoxidative stress. However,
oxidative stress at noncytotoxic levels is also
known to modulate GJIC (33-35).
The inhibitoryeffectofPAHs containing
bay or baylike regions on GJIC was more
pronounced with the 3-ring and fluorene-
type PAHs (Fig. 3, Fig. 4). These PAHswere
not very cytotoxic, even at higher doses (Fig.
5). Multiple baylike regions do not signifi-
candy increase the potencyofthecompound
to inhibit GJIC when compared to a com-
pound that contains a single baylike region.
For example, 9-methylanthracene and 9,10-
dimethylanthracene possess multiple baylike
regions, while 1-methylanthracene possesses
only one baylike region; yet, these com-
pounds all had similar dose-response curves
(Fig. 3). Also, there were no major differ-
ences in dose response between bay and bay-
like regions offluorene-type versus the3-ring
PAHs (Fig. 3, Fig. 4). Furthermore, no sig-
nificant differences were observed in the
inhibition ofGJIC by PAHs containing bay
versus baylike regions. For example, phenan-
threne and fluoranthene, which contain bay
regions, exhibited similar dose-response
curves as compared to 1-methylanthracene,
9-methylanthracene, and 1-methylfluorene,
which contain baylike regions (Fig. 3, Fig.
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Figure 7. Cytotoxic dose response of 1-methyl-
naphthalene attwo different incubation times.
4). However, fluorene, which contains no
bay region, did inhibit GJIC, albeit at a
higher dose (Fig. 4). Apparently, the pentyl
ring offluorene increased the toxic effect of
the 3-ring PAH. Inhibition ofGJIC by these
PAHs was also a reversible process (Fig. 8)
which is consistent with the reversible nature
oftumorpromotion in vivo(19).
Inhibition occurred in a short period of
time for all ofthe PAHs (Fig. 9), indicating
that the gap junctions are being modified at
the posttranslational level. The more water-
soluble GJIC-inhibiting PAHs, which are
the PAHs with lower log KO, values, down
regulated GJIC in a shorter time than the
less water-soluble PAHs (Fig. 10). This lin-
ear relationship oflog KoW versus inhibition
time ofa PAH (Fig. 10) implies more effi-
cient diffusion and greater bioavailability of
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Figure 8. The recovery time after inhibition of gap
junctional intercellular communication (GJIC) by
polycyclic aromatic hydrocarbons (PAHs). The
incubation times were 5 min for 1-methyinaphtha-
lene and 2-methyinaphthalene, 20 min for 1-
methylanthracene and 9-methylanthracene, and
10 min for all other PAHs. The rate of dye migra-
tion in the control was 95.8 ± 36.0 pm/min (mean ±
standard deviation).
the more water soluble PAHs to the cell
plasma membrane receptor.
The tumor-promoting activity of the
'PAHs we tested has not been extensively
studied. Nevertheless, there is some evidence
that PAHs containing bay regions are cocar-
cinogenic in animals, as ilustrated by the fact
that the carcinogenicity ofbenzo(a)pyrene
was enhanced by phenanthrene, fluoran-
thene, and 3-methylcholanthrene (36-38).
Also, the promoting effect ofbenzo(a)pyrene
was enhanced bybenz(a)anthracene, phenan-
threne, fluoranthene, and 3-methylcholan-
threne (38-40). These cocarcinogenic PAHs,
all ofwhich contain bay and baylike regions,
are not complete carcinogens. In particular,
fluoranthene and phenanthrene have been
shown not to be tumor initiators (7,25,
37,41) and benz(a)anthracene exhibits only
weaktumorinitiatingactivity (42).
The methylated forms of PAHs have
also been shown to be more carcinogenic
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Figure 9. Time response of cells to inhibition of
gap junctional intercellular communication (GJIC)
by various polycyclic aromatic hydrocarbons. The
rate ofdye migration in the control was 89.5 ± 20.8
pm/min (mean ± standard deviation).
Table 1. The values of the parameters of a sigmoid equation (Equation 1) used to calculate the time at 0.5
fraction ofthe controlforeach polycyclic aromatic hydrocarbon shown in Figure 10.
Parameters ofa sigmoid equationa
Polycyclic aromatic hycarbons a b c d
1-Methyinaphthalene 0.8061 2.131 0.183 0.2105
2-Methyinaphthalene 0.9038 1.062 0.2095 0.2036
1-Methylanthracene 0.7006 1.826 1.936 0.2934
9-Methylanthracene 0.7545 1.881 1.616 0.2593
Dimethylanthracene 0.7831 1.519 1.807 0.245
Phenanthrene 0.9507 0.8556 1.961 0.1899
Fluorene 0.554 1.239 0.7618 0.3543
1-Methylfluorene 2.684 0.7432 -1.242 0.2365
Fluoranthene 0.8806 1.013 1.824 0.2314
&The values ofthe parameters were obtained by fitting a sigmoidal curve using the Marquardt-Levenberg algorithm of a least squares fit to
each ofthe time response data in Figure 9.
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Figure 10. The linear relationship of the log K.,
versus the time required for a polycyclic aromatic
hydrocarbon to inhibit gap junctional intercellular
communication at 0.5 fraction of the control (FOC).
The values of the abscissa were obtained by cal-
culating the time in which inhibition occurred at a
value 0.5 of the FOC using Equation 1 and the
numerical parameters in Table 1. The K values
were obtained from Mackay et a]. (63). The log
K(w =0.60(min) + 3.52; l = 0.69.
than their parent counterparts (7,43-50).
The increased carcinogenicity ofmethylated
versus the unmethylated PAHs is impor-
tant, considering the growing evidence that
bioalkylation plays an important role in the
activation pathway of converting noncar-
cinogenic PAHs to carcinogenic PAHs
(50-52). Methyl substitution, which results
in the formation ofbaylike regions, occurs
in vivo at the mesoanthracenic positions
(43,50,51,53). Methylated PAHs can
undergo further metabolism in which
microsomal enzymes hydroxylate methyl
groups (43,54,55) and hepatic sulfotrans-
ferase enzymes catalyze the formation of
sulfate esters with the hydroxymethyl
groups (55-58).
All of the studies done to determine the
carcinogenicity of methylated PAHs and
their oxidized products focused on either
mutagenicity or complete carcinogenicity.
However, mutagenicity of strong elec-
trophiles does not always correlate with car-
cinogenicity, and complete carcinogens must
also induce tumor promotion through a
series ofepigenetic events (59)~. For example,
5-methylchrysene is more carcinogenic than
the unmethylated parent compound but the
higher carcinogenic potential of 5-
methylchrysene and its more electrophylic
metabolites could not be related to its muta-
genic potential (60). Thus, the fraction of
methylated PAHs that are not further
metabolized into strongelectrophiles can still
exr uoiei efec at th prmto-
aleieei stg ofcne.Sm tde
have shown PAHs to be epigenetically active,
such as benzo(a)pyrene and 7,12-dimethyl-
benz(a)anthracene, which can increase intra-
cellularCa2+ and cell proliferation in primary
human epithelial cells (61). Benzo(a)pyene
has also been shown to induce the prolifera-
tion ofvascular smooth musde cells that do
not involve the mutational activation ofc-
Ha, c-Ki-, or N-rasgenes (62). Determining
structure-activity relationships relative to
intracellular and intercellular communica-
tion processes involved in the promotional
stages ofcancershould help in predicting the
carcinogenicity of the many different PAHs
in ourenvironment.
Although in vitro results are difficult to
extrapolate to in vivo situations pertaining
to the carcinogenic risk ofa chemical, some
useful information can be obtained from in
vitro experiments. For instance, in vitro
assays are usually better suited for studying
structure-activity relationships at a more
mechanistic level, which can increase our
ability to predict the potency oftumor pro-
moters based on chemical structure. Also,
our in vitro results show a threshold level of
no effect, which suggests that it should be
possible to determine threshold levels when
conducting in vivo experiments. Further,
these in vitro studies can ultimately reduce
the extent ofwhole-animal testing. In par-
ticular, our results show that the effects of
dose, time response, and time ofrecovery of
the 3-ring and fluorene-type PAHs on
GJIC were similar (Fig. 3, Fig. 4, Fig. 8,
Fig. 9). These results suggest a similar
mechanism of action. Therefore, in vivo
experiments could be minimized by ran-
domly selecting one or two ofthese chemi-
cals rather than testingall ofthem.
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